SEC Form 4 · accession 0001140361-17-042207
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C Farrell
Director
Period of report
Nov 9, 2017
Accepted (ET)
Nov 13, 2017 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 9, 2017 | M | 11,815 | $52.02 | A | 306,615 | D | |
| ResMed Common Stock | Nov 9, 2017 | M | 20,492 | $58.24 | A | 327,107 | D | |
| ResMed Common Stock | Nov 9, 2017 | M | 3,625 | $27.58 | A | 330,732 | D | |
| ResMed Common Stock | Nov 9, 2017 | M | 82,460 | $27.58 | A | 413,192 | D | |
| ResMed Common StockF1 | Nov 9, 2017 | S | 11,815 | $82.71 | D | 401,377 | D | |
| ResMed Common StockF2 | Nov 9, 2017 | S | 20,492 | $82.70 | D | 380,885 | D | |
| ResMed Common StockF3 | Nov 9, 2017 | S | 3,625 | $82.69 | D | 377,260 | D | |
| ResMed Common StockF4 | Nov 9, 2017 | S | 82,460 | $82.70 | D | 294,800 | D | |
| ResMed Common StockF5 | Nov 10, 2017 | F | 1,858 | $83.06 | D | 292,942 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Stock Option PlanF6 | $52.02 | Nov 9, 2017 | M | 11,815 | D | Nov 11, 2015 | Nov 19, 2021 | ResMed Common Stock | 11,815 | 0 | D |
| Resmed Stock Option PlanF6 | $58.24 | Nov 9, 2017 | M | 20,492 | D | Nov 11, 2016 | Nov 19, 2022 | ResMed Common Stock | 20,492 | 0 | D |
| Resmed Stock Option PlanF6 | $27.58 | Nov 9, 2017 | M | 3,625 | D | Nov 11, 2012 | Nov 16, 2018 | ResMed Common Stock | 3,625 | 0 | D |
| Resmed Stock Option PlanF6 | $27.58 | Nov 9, 2017 | M | 82,460 | D | Nov 11, 2012 | Nov 16, 2018 | ResMed Common Stock | 82,460 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from 82.51 to 82.88. The price reported above represents the weighted average sales price.
- F2This transaction was executed in multiple trades at prices ranging from 82.53 to 82.87. The price reported above represents the weighted average sales price.
- F3This transaction was executed in multiple trades at prices ranging from $82.51 to $82.82. The price reported above reflects the weighted average sale price.
- F4This transaction was executed in multiple trades at prices ranging from 82.49 to 82.89. The price reported above represents the weighted average sales price.
- F5Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
- F6Represents date options first became exercisable. Options vested 1/4 per year.